Effect of neuroendocrine differentiation on therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer. Prospective ctDNA genotyping for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results